Gemcitabine hydrochloride and Speech impairment (adult) - a phase IV clinical study of FDA data

Summary:

Speech impairment (adult) is reported as a side effect among people who take Gemcitabine hydrochloride (gemcitabine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cisplatin, and have Neoplasm malignant.

The phase IV clinical study analyzes which people have Speech impairment (adult) when taking Gemcitabine hydrochloride. It is created by eHealthMe based on reports of 14,753 people who have side effects when taking Gemcitabine hydrochloride from the FDA, and is updated regularly.

What is Gemcitabine hydrochloride?

Gemcitabine hydrochloride has active ingredients of gemcitabine hydrochloride. eHealthMe is studying from 14,775 Gemcitabine hydrochloride users. Check the latest studies of Gemcitabine hydrochloride.

What is Speech impairment (adult)?

Speech impairment (adult) (inability to speak (adult)) is found to be associated with 2,140 drugs and 3,591 conditions by eHealthMe. Check the latest studies of Speech impairment (adult).

On Jul, 15, 2026

14,753 people reported to have side effects when taking Gemcitabine hydrochloride.
Among them, 31 people (0.21%) have Speech impairment (adult).

Could Gemcitabine hydrochloride cause Speech impairment (adult)?

Among these 31 people:

How long have people been on Gemcitabine hydrochloride when they have Speech impairment (adult)? *

What is the gender of people who have Speech impairment (adult) when taking Gemcitabine hydrochloride? *

female: 53.57 %
male: 46.43 %

What is the age of people who have Speech impairment (adult) when taking Gemcitabine hydrochloride? *

What are other drugs people take besides Gemcitabine hydrochloride? *

What are other side effects people have besides Speech impairment (adult)? *

Vision Blurred: 9 people, 29.03%
Fever: 9 people, 29.03%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 8 people, 25.81%
Anaemia (lack of blood): 8 people, 25.81%
Head Injury: 6 people, 19.35%
Blood Magnesium Abnormal: 6 people, 19.35%
Vitamin D Abnormal: 6 people, 19.35%
Aneurysm (enlargement of an artery caused by a weakening of the artery wall): 6 people, 19.35%
Peripheral Vascular Disorder: 6 people, 19.35%
Blood Calcium Abnormal: 6 people, 19.35%

What are the existing conditions these people have? *

Abdominal Pain: 3 people, 9.68%
Neoplasm Malignant (cancer tumour): 3 people, 9.68%
Pancreatic Carcinoma (pancreatic cancer): 2 people, 6.45%
Gastric Disorder (disease of stomach): 2 people, 6.45%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 2 people, 6.45%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 6.45%
Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 6.45%
Pain: 2 people, 6.45%
Oesophageal Squamous Cell Carcinoma (cancer that begins in flat cells lining the oesophagus): 2 people, 6.45%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Gemcitabine hydrochloride and have Speech impairment (adult)?

- Check whether Speech impairment (adult) is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemcitabine hydrochloride:

Gemcitabine hydrochloride (14,775 reports)

Browse all side effects of Gemcitabine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Speech impairment (adult):

Speech impairment (adult) (2,140 drugs)

Browse all the conditions that are associated with Speech impairment (adult):

Speech impairment (adult) (3,591 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gemcitabine hydrochloride (the active ingredients of Gemcitabine hydrochloride) and Gemcitabine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.